Evidence map›Paper›PMID 30508304›Full record

ArticleEuropean journal of immunology2019

Self-glycerophospholipids activate murine phospholipid-reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading.

Ramesh Chandra Halder, Cynthia Tran, Priti Prasad, Jing Wang, Dhiraj Nallapothula, Tatsuya Ishikawa, Meiying Wang, Dirk M Zajonc, Ram Raj Singh

Open access · greenAbstract read
In one paragraph

Article in European journal of immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ramesh Chandra HalderAutoimmunity and Tolerance Laboratory, Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
Cynthia TranAutoimmunity and Tolerance Laboratory, Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
Priti PrasadAutoimmunity and Tolerance Laboratory, Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
Jing WangDivision of Immune Regulation, La Jolla Institute for Immunology, La Jolla, CA, USA.
Dhiraj NallapothulaAutoimmunity and Tolerance Laboratory, Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
Tatsuya IshikawaAutoimmunity and Tolerance Laboratory, Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
Meiying WangAutoimmunity and Tolerance Laboratory, Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
Dirk M ZajoncDivision of Immune Regulation, La Jolla Institute for Immunology, La Jolla, CA, USA.
Ram Raj SinghAutoimmunity and Tolerance Laboratory, Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.ORCID 0000-0002-6831-4538
University of California, Los Angeles · USLa Jolla Institute for Immunology · USUniversity College Ghent · BE

Funding

ZWITTERION SURFACTANT DDMAB FOR IMPROV STABIL OF PROTEINP41RR001209 · NCRR · STANFORD UNIVERSITY · PI SCOTT, EMILY E · 1985 to 2011
$38.9M
X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
Training in Molecular ToxicologyT32ES015457 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALLARD, PATRICK, HANKINSON, OLIVER NMN · 2008 to 2025
$4.0M
Gender Bias in Lupus: Contribution of Sex ChromosomesR01AR056465 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGH, RAM RAJ · 2008 to 2012
$2.3M
Pathogenesis of Lupus DermatitisR01AI080778 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGH, RAM RAJ · 2009 to 2013
$2.2M
Structural Immunology of CD1 and CD1-TCR ComplexesR01AI074952 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI ZAJONC, DIRK M · 2009 to 2013
$1.8M
Kidney Damage in Murine LupusR01AR050797 · NIAMS · UNIVERSITY OF CINCINNATI · PI SINGH, RAM RAJ · 2003 to 2006
$1.4M
Peptide Gene Vaccination in LupusR01AR047322 · NIAMS · UNIVERSITY OF CINCINNATI · PI SINGH, RAM RAJ · 2001 to 2005
$1.3M
Decidual T Cells in Immune-mediated Pregnancy LossR21HD082812 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGH, RAM RAJ · 2015 to 2016
$421k
The Molecular Defects of Mesenchymal Stem Cells in Systemic Lupus ErythematosusF31AR063603 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TRAN, CYNTHIA · 2013 to 2017
$193k
Phospholipid-reactive T cells in Pregnancy LossR03HD067413 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HALDER, RAMESH CHANDRA · 2011 to 2012
$154k
NCRR NIH HHS P41 RR001209NIAID NIH HHS R01 AI074952NIAID NIH HHS R01 AI080778NIAMS NIH HHS F31 AR063603NIAMS NIH HHS R01 AR047322NIAMS NIH HHS R01 AR050797NIAMS NIH HHS R01 AR056465NICHD NIH HHS R03 HD067413NICHD NIH HHS R21 HD082812NIEHS NIH HHS T32 ES015457NIGMS NIH HHS P41 GM103393
6 · The paper itself

Abstract

Glycosphingolipids and glycerophospholipids bind CD1d. Glycosphingolipid-reactive invariant NKT-cells (iNKT) exhibit myriad immune effects, however, little is known about the functions of phospholipid-reactive T cells (PLT). We report that the normal mouse immune repertoire contains αβ T cells, which recognize self-glycerophospholipids such as phosphatidic acid (PA) in a CD1d-restricted manner and don't cross-react with iNKT-cell ligands. PA bound to CD1d in the absence of lipid transfer proteins. Upon in vivo priming, PA induced an expansion and activation of T cells in Ag-specific manner. Crystal structure of the CD1d:PA complex revealed that the ligand is centrally located in the CD1d-binding groove opening for TCR recognition. Moreover, the increased flexibility of the two acyl chains in diacylglycerol ligands and a less stringent-binding orientation for glycerophospholipids as compared with the bindings of glycosphingolipids may allow glycerophospholipids to readily occupy CD1d. Indeed, PA competed with α-galactosylceramide to load onto CD1d, leading to reduced expression of CD1d:α-galactosylceramide complexes on the surface of dendritic cells. Consistently, glycerophospholipids reduced iNKT-cell proliferation, expansion, and cytokine production in vitro and in vivo. Such superior ability of self-glycerophospholipids to compete with iNKT-cell ligands to occupy CD1d may help maintain homeostasis between the diverse subsets of lipid-reactive T cells, with important pathogenetic and therapeutic implications.

Indexed as

Antigens, CD1dDendritic CellsLymphocyte ActivationNatural Killer T-CellsPhosphatidic AcidsAnimalsCrystallography, X-RayGalactosylceramidesMiceMice, KnockoutAntigens, CD1dCD1d antigen, mouseGalactosylceramidesPhosphatidic AcidsCD1diNKT cellsphosphatidic acidphospholipidphospholipid-reactive T cells

Identifiers

PMID30508304
PMCPMC6405219
OpenAlexW2902694267

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.